Scholars Central

ArticlePublished 2021

WNT5A and IL10 in obese patients with insulin resistance

Authors: A.A. Komar, D.A. Skuratovskaia, M.A. Vulf, L.S.Litvinova

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: The anti-inflammatory cytokine interleukin-10 (IL10) may play a protective role in type 2 diabetes (T2D). The Wnt5a signaling pathway regulates the production of a wide range of cytokines in stellate cells of the liver, so we suggest a relationship between the expression of the WNT5a gene in the liver and the content of IL-10 in the circulation in obese patients with and without T2D. Methodology & Theoretical Orientation: Serum glucose levels were determined on a biochemical analyzer; the concentration of IL10 in blood plasma - by flow fluorimetry; WNT5a gene expression level - by PCR; quantitative content of protein WNT5A – by Western Blotting. Findings: Expression of the gene Wnt5a in the group of obese patients without diabetes increased by 1.7 times (p<0.05); the group of obese patients with diabetes increased by 1.47 times (p<0.05).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in British Journal of Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBritish Journal of Research
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “A.A. Komar”
  • BylineArticles whose byline prints “D.A. Skuratovskaia”
  • BylineArticles whose byline prints “M.A. Vulf”
  • BylineArticles whose byline prints “L.S.Litvinova”